Exact Sciences to participate in May investor conferences
MADISON, Wis., May 3, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participate by webcast.
- BofA Securities Virtual Healthcare Conference
Fireside Chat on Wednesday, May 12, 2021 at 1:15 p.m. EDT
- UBS Global Healthcare Virtual Conference
Fireside Chat on Tuesday, May 25, 2021 at 4:00 p.m. EDT
The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Exact Sciences Corp.
View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-may-investor-conferences-301281678.html
SOURCE EXACT SCIENCES CORP
--SVB Leerink Adjusts Exact Sciences PT to $170 From $180, Maintains Outperform Rating
MT Newswires 05/05 10:22 ET
--UBS Adjusts Exact Sciences' Price Target to $139 From $154; Neutral Rating Kept
MT Newswires 05/05 09:36 ET
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Margins Down
Yahoo 05/05 08:29 ET
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
Yahoo 05/05 06:01 ET
Exact Sciences (EXAS) Q1 2021 Earnings Call Transcript
Yahoo 05/05 03:31 ET
Shares of Cancer Researchers Exact Sciences and Invitae Are Sliding. Here’s Why.
Yahoo 05/04 18:09 ET
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
Yahoo 05/04 17:25 ET
Exact Sciences Q1 Loss Narrows, Revenue Gain Also Tops Estimates; FY21 Outlook In Line
MT Newswires 05/04 16:10 ET
-- Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Loss $-0.18, vs. Street Est of $-0.94
MT Newswires 05/04 16:01 ET
-- Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $402.1M, vs. Street Est of $388.6M
MT Newswires 05/04 16:00 ET